Exhibit 10.22 DISTRIBUTION AGREEMENT THIS AGREEMENT, effective as of August 28, 1998, between CARDIOVASCULAR DIAGNOSTICS, INC., a corporation organized and existing under the laws of North Carolina, with its principal offices located at 5301 Departure...Distribution Agreement • October 22nd, 1998 • Pharmanetics Inc • North Carolina
AMONG PHARMANETICS, INC.Shareholders' Agreement • May 14th, 2003 • Pharmanetics Inc • Electromedical & electrotherapeutic apparatus • North Carolina
Tenant: PHARMANETICS, INC., a North Carolina corporationLease Agreement • March 30th, 2001 • Pharmanetics Inc • Electromedical & electrotherapeutic apparatus
RECITALSCommon Stock Purchase Agreement • May 14th, 2003 • Pharmanetics Inc • Electromedical & electrotherapeutic apparatus • North Carolina
AMONGRegistration Rights Agreement • May 14th, 2003 • Pharmanetics Inc • Electromedical & electrotherapeutic apparatus • North Carolina
WARRANT TO PURCHASE COMMON STOCK of PHARMANETICS, INC.Pharmanetics Inc • March 1st, 2000 • Electromedical & electrotherapeutic apparatus • Delaware
ASSET PURCHASE AGREEMENT ------------------------ THIS ASSET PURCHASE AGREEMENT (with all exhibits, schedules and other attachments hereto, this "Agreement") is made and entered into this 15th day of June, 1999 by and among COEUR LABORATORIES, INC., a...Noncompetition and Confidentiality Agreement • June 28th, 1999 • Pharmanetics Inc • Electromedical & electrotherapeutic apparatus • North Carolina
Page ---- 1. DEFINITIONS 1 2. SALE AND PURCHASE OF Shares.................................................. 1 2.1 Sale and Purchase of Shares............................................. 1 2.2...Stock Purchase and Warrant Agreement • May 14th, 2003 • Pharmanetics Inc • Electromedical & electrotherapeutic apparatus • Delaware
Exhibit 10.23 COMMON STOCK PURCHASE AGREEMENT This Common Stock Purchase Agreement (the "Agreement") is made as of August 28, 1998, between Cardiovascular Diagnostics, Inc., a North Carolina corporation (the "Company"), and Chiron Diagnostics...Common Stock Purchase Agreement • October 22nd, 1998 • Pharmanetics Inc • North Carolina
Exhibit 10.24 SERIES A PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT This SERIES A PREFERRED STOCK PURCHASE AND WARRANT AGREEMENT (the "Agreement") dated February 24, 2000 is entered into by and between PharmaNetics, Inc., a North Carolina...Series a Preferred Stock and Warrant Purchase Agreement • March 1st, 2000 • Pharmanetics Inc • Electromedical & electrotherapeutic apparatus • Delaware
MASTER SECURITY AGREEMENT dated as of November 20, 2002 (“Agreement”)Master Security Agreement • July 30th, 2003 • Pharmanetics Inc • Electromedical & electrotherapeutic apparatus
THIS AGREEMENT is between General Electric Capital Corporation (together with its successors and assigns, if any, “Secured Party”) and Cardiovascular Diagnostics, Inc. (“Debtor”). Secured Party has an office at 401 Merritt 7 Suite 23, Norwalk, CT 06851-1177. Debtor is a corporation organized and existing under the laws of the state of North Carolina. Debtor’s mailing address and chief place of business is 9401 Globe Center Drive, Suite 140, Morrisville, NC 27560.
COLLABORATIVE DEVELOPMENT AGREEMENTCollaborative Development Agreement • July 30th, 2003 • Pharmanetics Inc • Electromedical & electrotherapeutic apparatus • Delaware
This Agreement is made and entered into this 30th day of August, 2000 by and between PHARMANETICS, INC., a North Carolina corporation (“PharmaNetics”), and AVENTIS PHARMACEUTICALS PRODUCTS INC., a Delaware corporation (“Aventis”). PharmaNetics and Aventis are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
EMPLOYMENT AGREEMENTEmployment Agreement • May 14th, 2004 • Pharmanetics Inc • Electromedical & electrotherapeutic apparatus • North Carolina
THIS EMPLOYMENT AGREEMENT (the “Agreement”), effective as of the 2nd day of April, 2004 (the “Effective Date”), by and between PharmaNetics, Inc., a North Carolina corporation (the “Company”), and John P. Funkhouser (the “Employee”), an individual residing in Wake County, North Carolina.
AGREEMENTAgreement • May 12th, 2003 • Pharmanetics Inc • Electromedical & electrotherapeutic apparatus
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned persons hereby agree to file with the Securities and Exchange Commission the Statement on Schedule 13G (the “Statement”) to which this Agreement is attached as an exhibit, and agree that such Statement, as so filed, is filed on behalf of each of them.
AMENDMENT #1 TO AMENDED AND RESTATED DISTRIBUTION AGREEMENTDistribution Agreement • October 28th, 2003 • Pharmanetics Inc • Electromedical & electrotherapeutic apparatus • North Carolina
This AMENDMENT #1 TO AMENDED AND RESTATED DISTRIBUTION AGREEMENT, effective as of October 23, 2003 (the “Amendment”), is by and between PHARMANETICS, INC., a corporation organized and existing under the laws of North Carolina, with its principal offices located at 9401 Globe Center Drive, Suite 140, Morrisville, North Carolina 27560 (“PharmaNetics”), and BAYER CORPORATION, an Indiana corporation, acting through its Diagnostics Division, with an office at 63 North Street, Medfield, Massachusetts (“Bayer Diagnostics”).
CORPORATE GUARANTYCorporate Guaranty • July 30th, 2003 • Pharmanetics Inc • Electromedical & electrotherapeutic apparatus
CHANGE OF CONTROL AGREEMENTChange of Control Agreement • July 30th, 2003 • Pharmanetics Inc • Electromedical & electrotherapeutic apparatus
This Change of Control Agreement (hereinafter, the “Agreement”) is made this 10th day of October, 1997, by and between Cardiovascular Diagnostics, Inc. a North Carolina corporation (“CVDI”), and John P. Funkhouser (“Funkhouser”).
TRANSITIONAL EMPLOYMENT AGREEMENTTransitional Employment Agreement • July 30th, 2003 • Pharmanetics Inc • Electromedical & electrotherapeutic apparatus • North Carolina
This TRANSITIONAL EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of July 4, 2003 (the “Effective Date”) by and between PharmaNetics, Inc., a North Carolina corporation (the “Company”), and James A. McGowan, a citizen and resident of Massachusetts (hereinafter “Employee”).
Exhibit 10.28 AMENDED AND RESTATED DISTRIBUTION AGREEMENT THIS AMENDED AND RESTATED DISTRIBUTION AGREEMENT, effective as of April 23, 2001 between PHARMANETICS, INC., a corporation organized and existing under the laws of North Carolina, with its...Distribution Agreement • April 27th, 2001 • Pharmanetics Inc • Electromedical & electrotherapeutic apparatus • North Carolina
THIS AMENDED AND RESTATED DISTRIBUTION AGREEMENT, effective as of April 23, 2001 between PHARMANETICS, INC., a corporation organized and existing under the laws of North Carolina, with its principal offices located at 9401 Globe Center Drive, Suite 140, Morrisville, North Carolina 27560 ("Pharmanetics"), and BAYER CORPORATION, an Indiana corporation, acting through its Diagnostics Division, with an office at 63 North Street, Medfield, Massachusetts ("Bayer Diagnostics").
